Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.32% Nasdaq Up0.49%

Bristol-Myers Squibb Company (BMY)

-NYSE

39.68 May 8, 4:02PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 3,831,000   4,191,000   3,736,000   4,443,000  
Cost of Revenue1,063,000  1,075,000  987,000  1,245,000  
Gross Profit 2,768,000   3,116,000   2,749,000   3,198,000  
Operating Expenses
Research Development930,000  1,082,000  951,000  962,000  
Selling General and Administrative1,183,000  1,355,000  1,238,000  1,228,000  
Non Recurring -  51,000  1,909,000  (130,000)
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 655,000   628,000   (1,349,000) 1,138,000  
Income from Continuing Operations
Total Other Income/Expenses Net19,000  35,000  50,000  (189,000)
Earnings Before Interest And Taxes674,000  513,000  (1,259,000)1,059,000  
Interest Expense -   -   -   -  
Income Before Tax674,000  513,000  (1,259,000)1,059,000  
Income Tax Expense51,000  (411,000)(546,000)251,000  
Minority Interest(14,000)1,000  2,000  (163,000)
Net Income From Continuing Ops609,000  775,000  (671,000)755,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 609,000   925,000   (711,000) 645,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 609,000   925,000   (711,000) 645,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.